ArticleJournal of ophthalmic & vision research2026
The Effect of Adjunctive Mitomycin C on Outcomes of Phaco-Viscocanalostomy in Glaucoma: A Randomized Controlled Trial.
Article in Journal of ophthalmic & vision research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate whether adjunctive intraoperative mitomycin C (MMC) improves intraocular pressure (IOP) control, visual acuity, or medication burden in patients undergoing phaco-viscocanalostomy for moderate to advanced open-angle glaucoma. Methods: This double-masked, parallel-group randomized clinical trial included 92 eyes of 92 patients with medically uncontrolled open-angle glaucoma, who were randomly assigned to undergo phaco-viscocanalostomy with ( Results: After excluding 15 patients (9 lost to follow-up and 6 intraoperative rupture of the trabeculo-Descemet's window), 77 patients (36 in the MMC group and 41 in the control group) were included in the final analysis. No statistically significant differences were found between groups at baseline (all Conclusion: The addition of MMC to phaco-viscocanalostomy did not provide statistically or clinically significant benefits in IOP control (clinically meaningful change defined as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.